Cardio Adrenergic Agents Flashcards
Use during CPR for asystole
Hemodynamic support after CABG
Anaphylaxis
Local/topical hemostatic
Epinephrine
Pressor agent of choice in septic/cardiogenic shock
NE
NE does what to renal BF
Decreases it
Phenylephrine
IV vasopressor agent
Over the counter nasal decongestant
Increases TPR, BP with reflex brady
Maintains BP in hypotensive states
Phenylephrine
Tx for Paroxysmal atrial tachycardia
Baroreceptor reflex slowing
Vasodilates renal, coronary, and mesenteric vascular beds
Dopamine via D1 receptors
Dopamine
Acts at D1 receptors causes mild increase in rate and force
Enhances kidney perfusion
High doses cause vasoconstriction and increased BP –> not a good thing in shock
Tx for shock, cardiogenic shock and unstable CHF
Dopamine
Must monitor carefully because too high of doses causes vasoconstriction and decreased tissue perfusion
Dobutamine
B1 selective agonist
Positive inotropic, and some chronotropic effects
CO increases
Little vascular effect
Dobutamine is used to treat
Cardiogenic shock, MI and CHF
Adverse effects of Dobutamine
May increase size of infarct, cause arrhythmia and increase work/O2 requirement of the heart (b1)
Clinical Use of A1 blockers
2nd/3rd line treatment of essential HTN
A1 Antagonist Effects
Decrease PVR, VR and Preload
Do not increase HR or CO
Do not increase NE release (no A2 block)
Decrease LDL and trigly while increasing HDL
Adverse Effects of A1 Antagonists
Marked postural hypotension and syncope, orthostatic hypotenison
Admin at bedtime
Most popular A1 Antagonist
Prazosin
Very short acting B blocker
Esmolol
Partial agonist B blocker with ISA
Acebutolol
Both A and B blockers
Labetolol & Carvediol
6 Clinical Uses of Cardioselective B Blockers
1) HTN: Decrease CO and TPR (SLOWLY OVER WEEKS)
2) Ischemic Heart Disease: Decreases cardiac work and O2 consumption
3) MI & Post MI Prophylaxis: protects against arrhythmias and limits infarct size (5-10days after)
4) CHF: Improves morbidity and mortality**
5) Arrhythmias: Sinus tachy and super ventricular beat suppressed
6) Thyrotoxicosis: block increased sensitivity of myocardium to betas
What are B blockers role in treating CHF?
Improve morbidity and mortality **
What are B blockers role in treating hyperthyroid pts?
Treats thyrotoxicosis
Hyperthyroid pt have increased B receptor sensitivity
Blockers reduce the sensitivity of myocardium to adrenergic stimulation
Pharmacological Effects of B Blockers Depends on
Existing SNS tone
B Blockers Effects on CO HR and PVR
Short term decrease in CO/HR
PVR increases to maintain BP as a result of B2 blocking/reflexes
Long term PVR returns to initial values or deceases in pt with HTN